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Life Sciences Patent Prosecution Pitfalls
By Robert E. Hanson, Ph.D., Esq.
Today’s Talk Will Cover …
• The unique application of  basic 
patentability requirements to 
biotechnology and life science inventions
• What it means to you
Non-Obviousness
• KSR v. Teleflex likely heightened bar for patentability. 
550 U.S. 398 (2007).
– A motivation or suggestion to combine elements to arrive at 
the invention need not be explicit in prior art.
– U.S. Sup. Ct.: “The combination of  familiar elements 
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according to known methods is likely to be obvious when it 
does no more than yield predicable results.”
• Take Away – obtain unexpected results for 
combination inventions, i.e., “more than predictable 
results”
– Having inventors run relevant experiments is critical.
Patentable Subject Matter Post-Bilski
• Bilski applied “machine-
transformation” test to 
find business method 
claims invalid. (Fed. Cir. 
2008) 
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• Test finds patentable 
subject matter only if: (1) 
tied to a particular machine 
or apparatus, or (2) 
transforms a particular 
article into a different state 
or thing. 
Relevance of  Bilski to the Life Sciences?
• Mayo v. Prometheus (Fed. Cir. 
2009): CAFC applies Bilski test 
to find claims patentable -
“administering a drug” and 
“determining the level” steps 
are considered transformative
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• Conclusion: include 
transformative step or 
apparatus element in claims
• But: U.S. Sup. Ct. expected to 
decide Bilski in 2010
Common Legal Issues – Biological  Deposits
• Required if  words or drawings alone are insufficient to 
describe and “enable” production of  biological material
– Examples: plant seeds; embryos; microorganisms; cell lines 
and hybridomas; viruses; plasmids and vectors
• Deposit must be made pre-filing for foreign patent 
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rights.
• Deposit can be delayed in the U.S., but only if  material 
adequately described
• Budapest Treaty approved depository required
– The ATCC or NRRL in the U.S.
Case Example – US 6,515,200
Seed deposit required?
1.  An interspecific hybrid 
Euphorbia plant produced 
from a cross between 
Euphorbia pulcherrima as a 
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female parent and 
Euphorbia cornastra as a 
male parent.
Case Example – US 6,515,200
Not in this case: a deposit 
is not required if  a 
biological material is 
“known and readily 
available.” See MPEP 
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2404.01 
Novelty of  Genetic Materials
• An enabling disclosure is required to destroy 
novelty.
• In re LeGrice, 301 F.2d 929 (CCPA 1962) Printed 
publication >1 yr prior to filing showed color 
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pictures of  claimed rose plant.  Held: not a bar 
to patentability – did not enable reproduction of  
the plant.
• But: watch out for on sale and public use bar.
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